Scientists
claim they are a step closer to developing a new drug to stop heart
attack in its tracks and reduce the damage caused,
without any side effects.
Researchers from the the Monash University in
Australia offer new hope to thousands of people who experience heart attacks
and heart failure - one of the major causes of death worldwide. They showed new
insights into a specific protein belonging to the family of G protein-coupled
receptors (GPCRs).
After
successfully combining two molecules, they say they are a step closer to
creating a brand new class of drug that is more targeted and could possess
minimal side effects. GPCRs play a role in virtually every biological process
and most diseases, including, cardiovascular disease, obesity and diabetes,
neuropsychiatric disorder, inflammation and cancer, researchers said.